SciELO - Scientific Electronic Library Online

 
vol.33 issue3Familial congenital cyanosis caused by Hb-M Yantai (α-76 GAC → TAC, Asp → Tyr)Molecular forms of butyrylcholinesterase and obesity author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Genetics and Molecular Biology

Print version ISSN 1415-4757

Genet. Mol. Biol. vol.33 no.3 São Paulo  2010 Epub June 25, 2010

http://dx.doi.org/10.1590/S1415-47572010005000056 

Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population

 

 

Mahsa M. AmoliI; Parvin AmiriI; Javad Tavakkoly-BazzazI; Elham CharmchiI; Jila HafeziyehI; Mohammad KeramatipourII; Maryam AbiriII; Shirin Hasani RanjbarI; Bagher LarijaniI

IEndocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran
IIDepartment of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran

Send correspondence to

 

 


ABSTRACT

The transcription factor 7-like 2 gene (TCF7L2) rs7903146 T allele is constantly associated with Type 2 diabetes in various populations and ethnic groups. Nevertheless, this has not been observed in two studies involving Arab populations. The aim of the present study was to investigate the association between TCF7L2 rs7903146 in an Iranian population. Type 2 diabetes patients (N = 258) and normal healthy control subjects (N = 168) from the same area, were examined. The ARMS-PCR (Amplification Refractory Mutation System) technique, subsequently validated by direct sequencing, was used for genotyping. Allele and genotype frequencies were significantly different between patients and controls TT vs. CT + CC [p 0.0081 OR 3.4 95%CI (1.27-11.9)] and T vs. C allele [p 0.02 OR 1.4 95%CI (1.03-1.9)]. Our data thus confirm the association between the rs7903146 T allele and T2D in an Iranian population, contrary to previous reports in Arab populations. This can possibly be attributed to differences in ethnic background or the effects of environmental factors.

Key words: TCF7L2, gene, polymorphism, T2DM.


 

 

Type 2 diabetes (T2D) is a common complex disorder resulting from the interplay of genetic and environmental factors (Gerich, 1998; Barroso, 2005). Following the report of a strong association between type 2 diabetes and a microsatellite marker located within intron 3 of the transcription factor 7-like 2 gene (TCF7L2) locus (Grant et al., 2006), a single nucleotide polymorphism (SNP) (rs7903146 allele T) within this gene was found to be in linkage disequilibrium with the said marker. This variant has been consistently associated with type 2 diabetes (T2D) in European, Asian and African populations (Cauchi et al., 2007), thereafter confirmed by gene-locus genotyping (Cauchi et al., 2007).

Other genetic loci, including PPARG and KCNJ11, have also been reproducibly associated with type 2 diabetes. More recently, 16 novel T2D susceptible loci have been identified (Sparsø et al., 2009). However, the magnitude of the TCF7L2 effect seems to be much higher than any other confirmed T2D candidate to date (Cauchi et al., 2007). Studies involving non-European ethnic backgrounds, including Indian (Chandak et al., 2007), Japanese (Hayashi et al., 2007) and Moroccan populations (Cauchi et al., 2007), also indicated positive association between TCF7L2 variants and T2D. This was also reported in Indian-Asian (Humphries et al, 2006; Bodhini et al., 2007) and Pakistani (Rees et al., 2008) populations. More recently, a lack of association between a TCF7L2 rs7903146 variant and type 2 diabetes was reported in Arabian Emirates (Saadi et al., 2008), as well as in an Arab population of Saudi origin (Alsmadi et al., 2008), although this was completely inconsistent with previous reports. The aim, hereby, was to investigate the association between the TCF7L2 rs7903146 variant and T2D in an Iranian population.

The study group comprised 258 type 2 diabetes patients, recruited from a diabetes clinic in the Aliebn Abitaleb hospital, Rafsanjan University, southeast Iran. Patients with diabetes were selected based on the following criteria: > 126 mg/dL on two different occasions and abstinence from insulin treatment. Patients presenting antiinsulin or anti-GAD antibodies were ruled out. 168 normal healthy control subjects were recruited from the same area, and were age-matched with the case population. In these, the absence of T2DM was certified by an expert endocrinologist, based on the above criteria. All the subjects selected for this study were of Fars origin. Population admixture is rare in this area and subjects with other ethnic backgrounds were not included in the study.

Following registration and the provision of personal and demographic data, 3-5 cc of venous blood was collected in EDTA tubes and stored at -20 C for DNA extraction. The study was approved by the Ethics committee of Tehran University. Informed consent was obtained from each patient involved. DNA was extracted by the salting-out method from anti-coagulated blood collected in EDTA tubes. ARMS-PCR (Amplification Refractory Mutation System) was employed for genotyping. The following primers were used:

Common forward primer: 5' -ggagc cgtca gatgg taatg -3'

TCF4-C: 5' -ggtg cctca tacgg caatt aaatt atatag -3'

TCF4-T: 5' -ggtg cctca tacgg caatt aaatt atataa -3'

β-actin-F: 5' -ctt cct tcc tgg gca tgg ag -3'

β-actin-R: 5' -tgg agg ggc cgg act cgt ca -3'

The PCR cycles were as follows: 5 min at 95 ºC, followed by 35 cycles of 30 s at 95º,30 sat 66ºC and 60sat 72 ºC. Final extension was 7 min at 72 ºC. The presence of PCR product (188 bp for TCF7L2 and 315 bp for β-actin) was verified on 2% agarose gel stained with ethidium bromide. Genotyping results were validated by direct sequencing.

Odd ratios (OR) and 95% confidence intervals (CI) were used for estimating the strength of association between different groups and alleles or genotypes of TCF7L2 gene polymorphism. Significance levels were defined through either Chi-quare or Fisher exact analyses with contingency tables. All analyses were carried out using STATA (v8) software.

Genotype frequencies did not differ from the expected Hardy-Weinberg ratios. The Male/Female ratio was 68/170 in diabetic patients and 58/72 in controls. The mean age was 53 ± 10 in diabetic patients and 52 ± 10 in normal controls. The mean BMI was 28 ± 4 in patients with diabetes and 26 ± 3 in normal controls.

Allele and genotype frequencies for TCF7L2 rs7903146 variation was significantly different in cases compared to the controls TT vs. CT +CC [p 0.0081 OR 3.4 95%CI(1.27-11.9)] and T vs. C allele [p 0.02 OR 1.4 95%CI (1.03-1.9)] Table 1.

It was found that the T allele of TCF7L2 rs7903146 is associated with T2D in the Iranian population. TCF7L2 is a high mobility group (HMG) box-containing transcription factor which is part of the Wnt signaling pathway (Grant et al., 2006). The expression of this gene is also associated with insulin secretion in human pancreatic β cells both in vivo and in vitro (Lyssenko et al., 2007)

In most recently published studies, it has been suggested that TCF7L2 is associated with impaired insulin secretion, but not with increased insulin resistance (Florez et al., 2006; Loos et al., 2007; Lyssenko et al., 2007). Also a multiplicative interaction between this variant and obesity or high BMI was inferred from two previous studies (Yan et al., 2008). Both imply that the risk of type 2 diabetes is greater in lean individuals carrying this polymorphism, whereas no significant association was noted in those obese or overweight. Therefore it seems that the SNP rs7903146 is a much more influential risk factor for lean individuals than for obese (Yan et al., 2008). Helgason et al. (2007) reported that the rs7903146 T allele, probably an ancestral and not causative variant, tags an unidentified functional variant lying outside the screened locus.

Our data confirm the association of this widely replicated variant with T2D risk in Iranians, in contrast with previous reports in Arab populations. Differences in ethnic background or the effect of environmental factors, such as life-style, may explain these discrepancies.

 

References

Alsmadi O, Al-Rubeaan K, Mohamed G, Alkayal F, Al-Saud H, Al-Saud NA, Al-Daghri N, Mohammad S and Meyer BF (2008) Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet 26:72.         [ Links ]

Barroso I (2005) Genetics of type 2 diabetes. Diabet Med 22:517-535.         [ Links ]

Bodhini D, Radha V, Dhar M, Narayani N and Mohan V (2007) The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism 56:1174-1178.         [ Links ]

Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, et al. (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: A global meta-analysis. J Mol Med 85:777-782.         [ Links ]

Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, Frayling TM and Yajnik CS (2007) Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50:63-67.         [ Links ]

Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D and Diabetes Prevention Program Research Group (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 20:241-250.         [ Links ]

Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503.         [ Links ]

Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320-323.         [ Links ]

Hayashi T, Iwamoto Y, Kaku K, Hirose H and Maeda S (2007) Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 50:980-984.         [ Links ]

Helgason A, Palsson S and Thorleifsson G (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218-225.         [ Links ]

Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, Hurel SJ, Li KW, Palmen J, Miller MA, Cappuccio FP, et al. (2006) Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 84:1005-1014.         [ Links ]

Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S and Wareham NJ (2007) TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.Diabetes 56:1943-1947.         [ Links ]

Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155-2163.         [ Links ]

Rees SD, Bellary S, Britten AC, O'Hare JP, Kumar S, Barnett AH and Kelly MA (2008) Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. BMC Med Genet 9:8.         [ Links ]

Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M and Nicholls MG (2008) Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Diabetes Res Clin Pract 80:392-398.         [ Links ]

Sparsø T, Grarup N, Andreasen C, Albrechtsen A, Holmkvist J, Andersen G, Jørgensen T, Borch-Johnsen K, Sandbaek A, Lauritzen T, et al. (2009) Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction. Diabetologia 52:1308-1314.         [ Links ]

Yan Y, North KE, Ballantyne CM, Brancati FL, Chambless LE, Franceschini N, Heiss G, Kottgen A, Pankow JS, Selvin E, et al. (2008) Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: The Atherosclerosis Risk in Communities study. Diabetes 58:285-289.         [ Links ]

 

 

Send correspondence to
Mahsa M Amoli
EMRC, Dr Shariati Hospital North Karegar St
14114 Tehran, Iran
E-mail: mahsa_amoli@hotmail.com

Received: October 20, 2009; Accepted: February 5, 2010.

 

 

Associate Editor: Peter Pearson
License information: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.